|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: E DIGITAL CORP, 10KSB40, EX-23.2, 2000-06-27 |
Next: CELLEGY PHARMACEUTICALS INC, SC 13D/A, 2000-06-27 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> MAR-31-2000
<PERIOD-START> APR-01-1999
<PERIOD-END> MAR-31-2000
<CASH> 3,294,366
<SECURITIES> 0
<RECEIVABLES> 272,732
<ALLOWANCES> 0
<INVENTORY> 79,599
<CURRENT-ASSETS> 3,655,156
<PP&E> 411,515
<DEPRECIATION> 269,144
<TOTAL-ASSETS> 3,806,884
<CURRENT-LIABILITIES> 1,285,412
<BONDS> 0
22,840
0
<COMMON> 126,261
<OTHER-SE> 2,372,371
<TOTAL-LIABILITY-AND-EQUITY> 3,806,884
<SALES> 387,576
<TOTAL-REVENUES> 489,962
<CGS> 328,158
<TOTAL-COSTS> 461,480
<OTHER-EXPENSES> 2,643,490
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 132,213
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,608,854)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,608,854)
<EPS-BASIC> (.05)
<EPS-DILUTED> (.05)
</TABLE>
|
|